These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 3166357)

  • 21. Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia.
    Friday KE; Failor RA; Childs MT; Bierman EL
    Arterioscler Thromb; 1991; 11(1):47-54. PubMed ID: 1988003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of fish oil supplementation for treatment of moderate elevation of serum cholesterol.
    Valdini AF; Glenn MA; Greenblatt L; Steinhardt S
    J Fam Pract; 1990 Jan; 30(1):55-9. PubMed ID: 2403586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.
    Mattson FH; Grundy SM
    J Lipid Res; 1985 Feb; 26(2):194-202. PubMed ID: 3989378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements.
    Inagaki M; Harris WS
    Atherosclerosis; 1990 Jun; 82(3):237-46. PubMed ID: 2375788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia.
    Gulesserian T; Widhalm K
    J Am Coll Nutr; 2002 Apr; 21(2):103-8. PubMed ID: 11999536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fish oil in diabetic nephropathy.
    Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
    Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.
    Kasim-Karakas SE; Herrmann R; Almario R
    Metabolism; 1995 Sep; 44(9):1223-30. PubMed ID: 7666799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the short-term administration of fish oil on serum lipoproteins in old people.
    Lehtonen A; Räihä I; Puumalainen R; Seppänen A; Marniemi J
    Gerontology; 1989; 35(5-6):311-4. PubMed ID: 2630386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
    Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
    Dallongeville J; Boulet L; Davignon J; Lussier-Cacan S
    Arterioscler Thromb; 1991; 11(4):864-71. PubMed ID: 2065040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet.
    Fisher WR; Zech LA; Stacpoole PW
    J Lipid Res; 1998 Feb; 39(2):388-401. PubMed ID: 9507999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
    Sanders TA; Sullivan DR; Reeve J; Thompson GR
    Arteriosclerosis; 1985; 5(5):459-65. PubMed ID: 4038159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity profile of gemfibrozil on the major plasma lipoprotein parameters.
    Sirtori CR; Franceschini G; Gianfranceschi G; Vaccarino V; Chiesa G; Maderna P; Bertoli M; Calabresi L
    Eur J Epidemiol; 1992 May; 8 Suppl 1():120-4. PubMed ID: 1505648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.
    Minihane AM; Khan S; Leigh-Firbank EC; Talmud P; Wright JW; Murphy MC; Griffin BA; Williams CM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1990-7. PubMed ID: 10938022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.